OA07794A - Immunomodulatory drug of biological origin and its method of preparation. - Google Patents

Immunomodulatory drug of biological origin and its method of preparation.

Info

Publication number
OA07794A
OA07794A OA58368A OA58368A OA07794A OA 07794 A OA07794 A OA 07794A OA 58368 A OA58368 A OA 58368A OA 58368 A OA58368 A OA 58368A OA 07794 A OA07794 A OA 07794A
Authority
OA
OAPI
Prior art keywords
biological origin
preparation
immunomodulatory drug
bacteria
bacteriophagic
Prior art date
Application number
OA58368A
Other languages
French (fr)
Inventor
Page Yves-Marie
Vanderhoven Christine
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of OA07794A publication Critical patent/OA07794A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1. Immunomodulating medicament of biological origin, of which the active principle is formed by the products of lysis or a fraction of these products of bacteria lysed by bacteriophagic route, characterised in that it contains, as active principle, the sterile lysis filtrate of at least two bacteria lysed by homologous bacteriophagic route ; the bacteria chosen being Klebsiella pneumoniae and Escherichia coli.
OA58368A 1983-08-17 1984-08-17 Immunomodulatory drug of biological origin and its method of preparation. OA07794A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8313362A FR2550707B1 (en) 1983-08-17 1983-08-17 IMMUNOMODULATOR OF BIOLOGICAL MEDICINE AND PROCESS FOR PREPARING THE SAME

Publications (1)

Publication Number Publication Date
OA07794A true OA07794A (en) 1986-11-20

Family

ID=9291646

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58368A OA07794A (en) 1983-08-17 1984-08-17 Immunomodulatory drug of biological origin and its method of preparation.

Country Status (22)

Country Link
EP (1) EP0139551B1 (en)
JP (1) JPS6069022A (en)
AT (1) ATE36240T1 (en)
AU (1) AU564652B2 (en)
CA (1) CA1229566A (en)
CS (1) CS270410B2 (en)
DD (1) DD232432A5 (en)
DE (1) DE3473228D1 (en)
DK (1) DK160807C (en)
ES (1) ES535213A0 (en)
FR (1) FR2550707B1 (en)
HU (1) HU193217B (en)
IL (1) IL72589A (en)
IN (1) IN161616B (en)
MA (1) MA20203A1 (en)
NO (1) NO843274L (en)
NZ (1) NZ209171A (en)
OA (1) OA07794A (en)
PT (1) PT79090B (en)
SU (1) SU1487815A3 (en)
YU (1) YU143284A (en)
ZA (1) ZA846151B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
FR2620130B1 (en) * 1987-09-08 1990-01-12 Lipha NOVEL WATER-SOLUBLE POLYSACCHARIDES, PROCESS FOR OBTAINING THEM, USE THEREOF AS MEDICAMENTS AND PREPARATION CONTAINING THEM
IL88480A0 (en) * 1987-11-27 1989-06-30 Univ Toronto Proteinaceous compositions
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
KR100965026B1 (en) 2002-02-13 2010-06-21 이뮤놀로지 래보러토리스 인코포레이티드 Compositions and methods for treatment of microbial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758977A (en) * 1969-11-17 1971-05-17 Glaxo Lab Ltd BIOCHEMICAL PROCESS
CH633188A5 (en) * 1978-05-26 1982-11-30 Om Laboratoires Sa MEDICINE FOR INFECTIOUS DISEASES OF THE RESPIRATORY TRACT.
CH639852A5 (en) * 1979-07-26 1983-12-15 Om Laboratoires Sa MEDICINE AGAINST INFECTIOUS DISEASES OF THE URINARY AND DIGESTIVE PATHWAYS.
US4322405A (en) * 1981-04-06 1982-03-30 Laboratoires Om Societe Anonyme Method for treating rheumatoid arthritis

Also Published As

Publication number Publication date
ATE36240T1 (en) 1988-08-15
DK160807C (en) 1991-10-07
DK393884A (en) 1985-02-18
FR2550707B1 (en) 1986-02-28
AU3193884A (en) 1985-02-21
YU143284A (en) 1991-02-28
CS270410B2 (en) 1990-06-13
SU1487815A3 (en) 1989-06-15
DD232432A5 (en) 1986-01-29
NO843274L (en) 1985-02-18
DK160807B (en) 1991-04-22
IL72589A (en) 1988-01-31
EP0139551A2 (en) 1985-05-02
DE3473228D1 (en) 1988-09-15
ES8602415A1 (en) 1985-12-01
AU564652B2 (en) 1987-08-20
HUT35013A (en) 1985-05-28
NZ209171A (en) 1988-10-28
IL72589A0 (en) 1984-11-30
IN161616B (en) 1988-01-02
FR2550707A1 (en) 1985-02-22
CS592184A2 (en) 1989-11-14
EP0139551B1 (en) 1988-08-10
HU193217B (en) 1987-08-28
CA1229566A (en) 1987-11-24
MA20203A1 (en) 1985-04-01
PT79090A (en) 1984-09-01
PT79090B (en) 1986-08-14
ES535213A0 (en) 1985-12-01
EP0139551A3 (en) 1985-07-10
JPS6069022A (en) 1985-04-19
ZA846151B (en) 1985-03-27
DK393884D0 (en) 1984-08-16

Similar Documents

Publication Publication Date Title
KR0145958B1 (en) Antibacterial agents
DK62286A (en) NON-ANTIBACTERIAL TETRACYCLINE PREPARATIONS WITH ANTICOLLAGENOLYTIC PROPERTIES
PH25319A (en)
PT76325B (en) Process for the preparation of polysaccharide-protein complexes from bacterial capsules
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
OA07794A (en) Immunomodulatory drug of biological origin and its method of preparation.
GR3002679T3 (en) Dihydropyridinamides, process for their preparation and their use in medicines
DK347788D0 (en) TEICOPLAN-SIMILAR COMPOUNDS, PROCEDURES AND MICRO-ORGANISMS FOR PRODUCING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
MC1977A1 (en) PROCESS FOR THE PREPARATION OF AN INHIBITOR OR DESTRUCTIVE COMPOSITION OF AT LEAST ONE SINGLE-CELL LIVING BEING CONTAINING FLUOR F AND LITHIUM LI +
ITMI922296A0 (en) PROCEDURE FOR THE PREPARATION OF STERILE BETA-LACTAM ANTIBIOTICS
FR2716203B1 (en) Process for the preparation of chlorinated violanthrones or isoviolanthrones.
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
NO883219D0 (en) PROCEDURE FOR THE PREPARATION OF BETA-LACTAM COMPOUND, INTERMEDIATE PRODUCT FOR THE PREPARATION OF IT, AND MEDICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIOLOGICAL INFECTIOUS DISEASES CONTAINING THIS.
GB8603962D0 (en) Chemical compositions
IT1235644B (en) INFRARED DRIVING PROCEDURE FOR MISSILE AND SYSTEM FOR IMPLEMENTING THIS PROCEDURE
EP0189587A3 (en) Method of sterilizing recombinant microorganism
ATE72818T1 (en) VANCOMYCIN-TYPE ANTIBIOTICS.
IT8620411A0 (en) PROCEDURE FOR THE PRODUCTION OF MIXED ZIRCONIUM AND TITANIUM DIPHOSPHATES AND THE PRODUCTS OBTAINED.
IT8848237A0 (en) PROCEDURE FOR THE PRODUCTION OF CRYSTALLINE TITANIUM, ZIRCONIUM AND MIXED ZIRCONIUM AND TITANIUM DIPHOSPHATES